Physician profile
Stephen J Lebitsch
NPI 1447311154
$3,385.94
in general payments reported to CMS, 2019-2025
16 companies · $1,051 in 2025
The $1,051 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $768 · 2022: $547 · 2023: $518 · 2024: $502 · 2025: $1,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,071.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,681.61 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Si-Bone, INC. | $428.16 | 2021-2022 | |
| Novo Nordisk INC | $243.43 | 2023-2025 | Wegovy |
| Scilex Pharmaceuticals INC. | $220.16 | 2021-2025 | |
| Boston Scientific Corporation | $185.39 | 2021-2023 | |
| Spr Therapeutics, INC | $171.43 | 2025 | Sprint Pns System |
| Endo Pharmaceuticals INC. | $138.67 | 2021-2022 | |
| Relievant Medsystems, INC. | $73.24 | 2023 | Intracept |
| Arbor Pharmaceuticals, INC. | $57.04 | 2021-2022 | |
| Heron Therapeutics, INC. | $45.43 | 2021-2022 | |
| Djo, LLC | $36.73 | 2025 | Cmf |
| Siemens Medical Solutions USA, INC. | $25.78 | 2021 | |
| Ge Healthcare | $24.87 | 2024 | |
| Endo USA, INC. | $19.86 | 2024 | Xiaflex |
| Vertex Pharmaceuticals Incorporated | $18.99 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $15.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Lebitsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.